Sunday, 28 September, 2025г.
russian english deutsch french spanish portuguese czech greek georgian chinese japanese korean indonesian turkish thai uzbek

пример: покупка автомобиля в Запорожье

 

Pembrolizumab is better than ipilimumab for advanced melanoma in phase III trial

Pembrolizumab is better than ipilimumab for advanced melanoma in phase III trialУ вашего броузера проблема в совместимости с HTML5
Prof Ribas presents the findings of a phase III trial, which showed pembrolizumab to be preferable to ipilimumab in advanced melanoma, at a press conference at AACR 2015.
Мой аккаунт